|
|
||||||||
1 Department of Immunoprophylaxis, Central Veterinary Laboratory, Box 8156 Dep, N-0033 Oslo, Norway
A Staphylococcus aureus vaccine containing whole, inactivated bacteria with pseudocapsule and
and ß toxoids with a mineral oil as adjuvant, was used in a field trial. Heifers were injected in the area of the supramammary lymph nodes with vaccine or placebo twice before calving and observed and sampled throughout their first lactation. Antibody response toward the pseudocapsule and the
toxin was significant in serum from the vaccinated cows. These antibody concentrations were significantly higher in serum and milk during the entire lactation compared with that of the controls. The antibody response to the ß toxin was moderate in serum from vaccinated cows; no differences in antibody concentrations in milk were significant between groups. The antibody response to the pseudocapsule consisted of the IgG1 and IgG2 isotypes, but, in milk, only the concentration of IgG1 was significantly increased in the vaccinated cows during the lactation compared with the control cows.
Key Words: Staphylococcus aureus vaccine mastitis field trial
Submitted on August 3, 1993
Accepted on January 13, 1994
This article has been cited by other articles:
![]() |
A. H. Kampen, T. Tollersrud, and A. Lund Staphylococcus aureus Capsular Polysaccharide Types 5 and 8 Reduce Killing by Bovine Neutrophils In Vitro Infect. Immun., March 1, 2005; 73(3): 1578 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fan, K. Plaut, A. J. Bramley, J. W. Barlow, S. A. Mischler, and D. E. Kerr Persistency of Adenoviral-Mediated Lysostaphin Expression in Goat Mammary Glands J Dairy Sci, March 1, 2004; 87(3): 602 - 608. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |